Publicacións (24) Publicacións de Sabela Sánchez Trigo

2023

  1. 1586 - CARACTERÍSTICAS DE LA INFECCIÓN POR SARS-COV-2 EN PACIENTES EN TRATAMIENTO CON ANTICUERPOS MONOCLONALES ANTI-CD20 DESDE EL INICIO DE LA PANDEMIA

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S426-S427

  2. 1706 - ¿COMO HEMOS MANEJADO LA INFECCIÓN POR SARS-COV-2 EN PACIENTES DIAGNOSTICADOS DE NEOPLASIAS HEMATOLÓGICAS EN TRATAMIENTO CON RITUXIMAB?

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S428-S429

  3. 1754 - CARACTERÍSTICAS CLÍNICAS Y EPIDEMIOLÓGICAS DE LOS PACIENTES INGRESADOS POR ENDOCARDITIS INFECCIOSA EN UN HOSPITAL DE SEGUNDO NIVEL

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S718-S720

  4. 7 - IMPACTO DE LA PANDEMIA POR COVID-19 EN LA INCIDENCIA DE COLONIZACIÓN-INFECCIÓN POR STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA.

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S806-S807

  5. BACTERIEMIA EN PERSONAS QUE VIVEN CON VIH A LO LARGO DE 34 AÑOS

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S706-S707

  6. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  2. Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry

    Seminars in Arthritis and Rheumatism, Vol. 55

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  2. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

    PLoS ONE, Vol. 16, Núm. 2 February

  3. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2017

  1. Treatment of Chronic Mucocutaneous Candidiasis, an Unsolved Issue. Case Report and Literature Review

    Journal of Clinical & Cellular Immunology, Vol. 08, Núm. 02

2014

  1. Calcinosis en Esclerosis Sistémica

    Galicia Clínica, Vol. 75, Núm. 4, pp. 204

2013

  1. Gastrointestinal disorders in primary immunodeficiencies

    European Journal of Internal Medicine, Vol. 24, pp. e239-e240

  2. Ocular granuloma as presentation of systemic sarcoidosis

    European Journal of Internal Medicine, Vol. 24, pp. e246-e247

2011

  1. Autoimmune hypothyroidism: Might its presence be useful to support the diagnosis of sarcoidosis in a patient with acute symmetrical oligoarthritis?

    Bratislava Medical Journal, Vol. 112, Núm. 6, pp. 355-356

  2. Hemoperitoneum due to spontaneous rupture of ovarian adenocarcinoma

    Emergency Radiology, Vol. 18, Núm. 3, pp. 267-269

2009

  1. Idiopathic thrombocytopenic purpura: Helicobacter pylori infection should be considered

    European Journal of Internal Medicine

  2. P0147 SARCOIDOSIS PRESENTING AS PULMONARY “COIN LESION”

    European Journal of Internal Medicine, Vol. 20, pp. S54